Results 201 to 210 of about 5,260,545 (402)

Effect of Drug Carrier Melting Points on Drug Release of Dexamethasone-Loaded Microspheres [PDF]

, 2017
Ji Hoon Park, Doo Yeon Kwon, Ji Yeon Heo, Seung Hun Park, Joon Yeong Park, Bong Lee, Jae Ho Kim, Moon Suk Kim   +7 more
openalex   +1 more source

Tumour–host interactions in Drosophila: mechanisms in the tumour micro‐ and macroenvironment

Molecular Oncology, EarlyView.
This review examines how tumour–host crosstalk takes place at multiple levels of biological organisation, from local cell competition and immune crosstalk to organism‐wide metabolic and physiological collapse. Here, we integrate findings from Drosophila melanogaster studies that reveal conserved mechanisms through which tumours hijack host systems to ...
José Teles‐Reis, Tor Erik Rusten
wiley   +1 more source

Mesoporous Potassium-Based Metal-Organic Framework as a Drug Carrier. [PDF]

ACS Cent Sci
Fang B, Shan T, Chen S, Pan F, Yang X, Xiao D, Huang F, Mao Z.   +7 more
europepmc   +1 more source

Aerodynamic Factors Responsible for the Deaggregation of Carrier-Free Drug Powders to Form Micrometer and Submicrometer Aerosols

, 2013
P. Worth Longest, Yoen‐Ju Son, Landon T. Holbrook, Michael Hindle   +3 more
openalex   +1 more source

Basroparib inhibits YAP‐driven cancers by stabilizing angiomotin

Molecular Oncology, EarlyView.
Basroparib, a selective tankyrase inhibitor, suppresses Wnt signaling and attenuates YAP‐driven oncogenic programs by stabilizing angiomotin. It promotes AMOT–YAP complex formation, enforces cytoplasmic YAP sequestration, inhibits YAP/TEAD transcription, and sensitizes YAP‐active cancers, including KRAS‐mutant colorectal cancer, to MEK inhibition.
Young‐Ju Kwon, Dong Young Kim, Yuna Kim, Uk‐Il Kim, Jae‐Sung Kim   +4 more
wiley   +1 more source

Corrigendum: Exosomes: Potential biomarkers and functions in head and neck squamous cell carcinoma

Frontiers in Molecular Biosciences, 2022
Ting Li, Juan Li, Haitao Wang, Jiayu Zhao, Mingze Yan, Hongjiang He, Shan Yu   +6 more
doaj   +1 more source

Graphene Oxide Incorporated Nanohybrid Aerogels as New Generation Drug Carrier Platforms. [PDF]

Gels
Çalışkan Salihi E, Hasan Niari Niar S, Ulucici EN, Gedik ET, Zengin FB, Samur F, Şahin SD, Taşkın T.   +7 more
europepmc   +1 more source

Antiviral and Antibacterial Sulfated Polysaccharide-Chitosan Nanocomposite Particles as a Drug Carrier. [PDF]

Molecules, 2023
Yin AY, Xu J, Yang CS, Hsu SH.
europepmc   +1 more source

Lactoferrin treatment activates acetylcholinesterase, decreasing acetylcholine levels in non‐small cell lung cancer (NSCLC) cell culture supernatants, inhibiting cell survival

FEBS Open Bio, EarlyView.
Representation of the suggested mode of action of lactoferrin (Lf) in nonsmall cell lung cancer (NSCLC) A549 cells. Lf induces activation of caspase‐3 by activating p53 and AChE leading to decreased ACh concentrations. In turn, ACh signaling leads to activation of VEGF and AKT and blocking of caspase‐3.
Stuti Goel, Caroline Wozniak, Aya Sabri, Ben Haddad, Brooke Lopo, Alvaro Cobos, Sarah Sarofim, Jeffrey Guthrie, Deborah Heyl, Hedeel Guy Evans   +9 more
wiley   +1 more source

Evaluation of drug carrier hepatotoxicity using primary cell culture models. [PDF]

Nanomedicine, 2023
Kibar G, Dutta S, Rege K, Usta OB.
europepmc   +1 more source